EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal Assessment of Exercise Capacity via Cardiopulmonary Exercise Testing in Heart Failure Patients with Improved and Persistently Reduced Ejection Fraction: Results from the IMPRO2VEMENT-HF Study

Longitudinale Beurteilung der Belastungsfähigkeit mittels Spiroergometrie bei Herzinsuffizienz mit verbesserter und persistierend reduzierter Ejektionsfraktion: Ergebnisse der IMPRO2VEMENT-HF-Studie

Diana Ladera-Santos iD, José López-Aguilera iD, Jesús Alberto Torres-Zamudio, Consuelo Fernández-Avilés iD, Jorge Perea-Armijo iD, Guillermo Gutiérrez Ballesteros iD, Gloria Heredia Campos, Luis Carlos Maestre Luque, Rafaela Luque López, Asunción García Merino, Ángela Heredia Torres, Juan Manuel García Medina und 10 weitere

Journal of Clinical Medicine · 28.10.2026 · 15 (21) · 8406

DOI: 10.3390/jcm15218406 ↗

Auf einen Blick

Bei 111 Patient:innen mit HFrEF verbesserten sich unter Verlaufskontrolle beide Gruppen in der Belastungsfähigkeit. HFimpEF zeigte jedoch eine stärkere Zunahme der prozentual vorhergesagten maximalen Sauerstoffaufnahme.

Fragestellung

Unterscheidet sich das Belastungsprofil per CPET zwischen HFimpEF und persistierend reduzierter Ejektionsfraktion bei HFrEF nach Therapieanpassung?

Methode

Längsschnitt-Kohortenstudie mit 111 HFrEF-Patient:innen; Vergleich von HFimpEF und HFprEF mittels baseline-adjustierter ANCOVA, Bootstrapping und Multiplikitätsanpassung.

Ergebnisse

111 Patient:innen: 69 HFimpEF und 42 HFprEF. Nach median 8,7 Monaten: ΔLVEF +19,9 % und NT-proBNP −557,6 pg/mL in HFimpEF. Prozent der vorhergesagten Peak-VO2: adjustierte Differenz +8,5 % (95 %-KI 1,2 bis 16,1; p = 0,021).

Schlussfolgerung der Autor:innen

Eine umfassende HFrEF-Behandlung verbessert die Belastungsfähigkeit in beiden Gruppen. HFimpEF zeigt zwar größere Zugewinne der normalisierten aeroben Kapazität, die funktionellen Verläufe bleiben insgesamt ähnlich.

Kernaussagen

  • 111 HFrEF-Patient:innen mit CPET im Verlauf
  • HFimpEF mit stärkerer Zunahme der prozentualen Peak-VO2
  • Weitere Funktionsparameter zwischen den Gruppen nicht signifikant unterschiedlich

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.10.2026. Verfasst von Diana Ladera-Santos und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Reina Sofia University Hospital, 14011 Cordoba, Spain. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Andalussian Cardiology Foundation, Andalusian Society of Cardiology.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with heart failure and reduced ejection fraction (HFrEF) who achieve improved ejection fraction (HFimpEF) after guideline-directed medical therapy exhibit superior prognosis. However, functional impairment remains a hallmark of HF.

Aims

To characterize and compare exercise capacity profiles via cardiopulmonary exercise testing (CPET) between patients with HFimpEF and those with persistently reduced ejection fraction (HFprEF) using a baseline-adjusted analysis.

Methods

Data from a longitudinal cohort of 111 HFrEF patients with baseline and follow-up CPET data (minimum 6-month follow-up) were analyzed. Patients were stratified into HFimpEF and HFprEF groups, according to the Universal Definition of HF. Changes between groups were evaluated using Analysis of Covariance (ANCOVA) adjusted for baseline values, with non-parametric Bootstrapping (2000 resamples) and multiplicity.

Results

We included 111 patients: 69 with HFimpEF (62.2%) and 42 with HFprEF (37.8%). At a median follow-up of 8.7 months, the HFimpEF group showed significantly greater reverse remodeling (adjusted ΔLVEF +19.9%, p < 0.001) and a greater reduction in NT-proBNP levels (−557.6 pg/mL, p = 0.042). Both groups demonstrated intra-group functional improvements. However, in adjusted between-group ANCOVA models, HFimpEF achieved a significantly greater recovery in percentage of predicted peak oxygen consumption (adjusted difference: +8.5%; 95% CI: 1.2 to 16.1; p = 0.021). Net adjusted between-group differences for absolute VO2peak gain, submaximal threshold, ventilatory efficiency and recovery kinetics did not reach statistical significance. Multivariate analysis identified older age (beta −0.261, p = 0.010), diabetes mellitus (beta −0.210, p = 0.023) and baseline VO2peak (beta −0.569, p < 0.001) as negative predictors of improvement.

Conclusions

Comprehensive HFrEF management improves exercise capacity across all patients. Although HFimpEF yields superior gains in normalized aerobic capacity, overall functional trajectories are largely comparable between phenotypes. This structural-functional decoupling underscores persistent residual limitations in HFimpEF, supporting CPET for longitudinal risk stratification.

Schlagwörter

Stichwörter der Autor:innen

CPETfunctional capacityimproved ejection fractionventricular remodeling

Autor:innen und Institutionen

  • Cardiology Department, Reina Sofia University Hospital, 14011 Cordoba, Spain.
  • Cordoba Biomedical Research Institute, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14011 Cordoba, Spain.
  • Cardiac Rehabilitation Unit, Cardiology Department, Reina Sofia University Hospital, 14011 Cordoba, Spain.
  • Heart Failure Unit, Cardiology Department, Reina Sofia University Hospital, 14011 Cordoba, Spain.
  • Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Carlos III Institute of Health, 28029 Madrid, Spain.
  • Faculty of Health Sciences, Universidad Internacional Isabel I de Castilla, 09003 Burgos, Spain.

ORCID-Profile: Diana Ladera-Santos, José López-Aguilera, Consuelo Fernández-Avilés, Jorge Perea-Armijo, Guillermo Gutiérrez Ballesteros, Álvaro Roldán-Guerra, Rafael González Manzanares, Dolores Mesa-Rubio, Juan Carlos Castillo-Domínguez, Martín Ruiz-Ortiz

Förderung

  • Andalussian Cardiology Foundation
  • Andalusian Society of Cardiology

Zitieren

APA

Ladera-Santos, D., López-Aguilera, J., Torres-Zamudio, J. A., Fernández-Avilés, C., Perea-Armijo, J., Gutiérrez Ballesteros, G., Heredia Campos, G., Maestre Luque, L. C., Luque López, R., García Merino, A., Heredia Torres, Á., García Medina, J. M., Segura Saint-Gerons, J. M., Roldán-Guerra, Á., Crespín-Crespín, M., Delgado-Ortega, M., González Manzanares, R., Mesa-Rubio, D., Pan-Álvarez Osorio, M., …, & Ruiz-Ortiz, M. (2026). Longitudinal Assessment of Exercise Capacity via Cardiopulmonary Exercise Testing in Heart Failure Patients with Improved and Persistently Reduced Ejection Fraction: Results from the IMPRO2VEMENT-HF Study. Journal of Clinical Medicine, 15(21), 8406. https://doi.org/10.3390/jcm15218406

Vancouver

Ladera-Santos D, López-Aguilera J, Torres-Zamudio JA, Fernández-Avilés C, Perea-Armijo J, Gutiérrez Ballesteros G, et al. Longitudinal Assessment of Exercise Capacity via Cardiopulmonary Exercise Testing in Heart Failure Patients with Improved and Persistently Reduced Ejection Fraction: Results from the IMPRO2VEMENT-HF Study. Journal of Clinical Medicine. 2026;15(21):8406. doi:10.3390/jcm15218406

BibTeX
@article{LaderaSantos2026,
  author = {Ladera-Santos, Diana and López-Aguilera, José and Torres-Zamudio, Jesús Alberto and Fernández-Avilés, Consuelo and Perea-Armijo, Jorge and Gutiérrez Ballesteros, Guillermo and Heredia Campos, Gloria and Maestre Luque, Luis Carlos and Luque López, Rafaela and García Merino, Asunción and Heredia Torres, Ángela and García Medina, Juan Manuel and Segura Saint-Gerons, José María and Roldán-Guerra, Álvaro and Crespín-Crespín, Manuel and Delgado-Ortega, Mónica and González Manzanares, Rafael and Mesa-Rubio, Dolores and Pan-Álvarez Osorio, Manuel and Anguita-Sánchez, Manuel and Castillo-Domínguez, Juan Carlos and Ruiz-Ortiz, Martín},
  title = {Longitudinal Assessment of Exercise Capacity via Cardiopulmonary Exercise Testing in Heart Failure Patients with Improved and Persistently Reduced Ejection Fraction: Results from the IMPRO2VEMENT-HF Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8406},
  doi = {10.3390/jcm15218406}
}
Kostenlos starten →